QYB declines, for the 13th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
January 2024 — Vol. 1, No. 1
Page 3 of 4 of this archive, newest first.
Also filed — page 3
the rolling newsroom, January 2024New Zealand health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Inspectors cite Halvard & Pike Apothecary of Portland, Maine over sterility assurance
The observation that closes a facility is rarely the dramatic one.
VendorInvestigate result on a Xi'an retatrutide lot lands 1.1 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
What changed at WXT in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
Independent analysis puts a BCH cagrilintide lot at 96.6%, against 93.4% on the certificate
The result is unremarkable. What the report omits is not.
CPC declines, for the 14th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
South Korea caps dulaglutide prescribing to 4 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.
South Africa pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
A shortage listing ends. 20 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Norway declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
From the floor in Hangzhou: 11 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Italy guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 23% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 8 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Suzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
A supplier suspends shipping to Canada after 24 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Canada caps exenatide prescribing to 11 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What a 39% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
From the floor in Xianning: 4 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a MKM cagrilintide lot at 98.9%, against 94.9% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.
Qingdao export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.